Impaired pro-islet amyloid polypeptide processing promotes beta-cell dysfunction in diabetes and islet transplants
Soaring rates of diabetes highlight the importance of controlling this global epidemic, with an estimated 415 million people thought to be living with diabetes in 2015. The defining characteristic of diabetes is elevated fasting blood glucose levels, or hyperglycemia, which if not controlled promote...
Main Author: | Courtade, Jaques |
---|---|
Language: | English |
Published: |
University of British Columbia
2016
|
Online Access: | http://hdl.handle.net/2429/59064 |
Similar Items
-
Pro-islet amyloid polypeptide and type 2 diabetes
by: Hull, Rebecca L.
Published: (1999) -
Chaperones ameliorate beta cell dysfunction associated with human islet amyloid polypeptide overexpression.
by: Lisa Cadavez, et al.
Published: (2014-01-01) -
The Mitochondrial Peptidase Pitrilysin Degrades Islet Amyloid Polypeptide in Beta-Cells.
by: Hanjun Guan, et al.
Published: (2015-01-01) -
In vitro and in vivo effects of exendin-4 on human islet amyloid polypeptide induced beta-cell dysfunction.
Published: (2013) -
Islet Amyloid Polypeptide: Structure, Function, and Pathophysiology
by: Rehana Akter, et al.
Published: (2016-01-01)